Logo image
Circulating MicroRNA as thrombosis sentinels: Caveats and considerations
Journal article   Peer reviewed

Circulating MicroRNA as thrombosis sentinels: Caveats and considerations

R. Baker, G. Gilmore, J. Jorritsma, Q. Hughes, J. Tiao and J. Tay
Seminars in Thrombosis and Hemostasis, Vol.44(3), pp.206-215
2017
url
Link to Published Version *Subscription may be requiredView

Abstract

The small noncoding RNAs, microRNAs (or miRNAs), have been implicated in a myriad of diseases and accumulating evidence indicate their potential high value as diagnostic biomarkers. Although their roles in hemostasis and coagulation pathways are less defined, many studies have demonstrated their participation in regulating key factors of hemostasis. However, the mounting challenges associated with the accurate measurement of circulating miRNAs and the involvement of platelet activation in contributing to the circulating miRNA expression profile introduce further complexity to the study of thrombosis-associated miRNAs. This review outlines the current knowledge of miRNAs that have been postulated to regulate key hemostatic factors, and miRNA diagnostic panels in thrombotic disease, with a focus on experimental fundamentals, such as selecting condition-specific reference controls, considerations that are crucial for accurate evaluation of miRNAs in the context of disease biomarkers.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
1 Clinical & Life Sciences
1.196 Micro & Long Noncoding RNA
1.196.68 MicroRNA in Cancer
Web Of Science research areas
Hematology
Peripheral Vascular Disease
ESI research areas
Clinical Medicine
Logo image